Clasp Therapeutics
Latest round
- Series A
Last raised
- Oct 2023
Total raised
- $72M
Investors
- 9
About Clasp Therapeutics
Based in Maryland, US, and founded in 2020, Clasp Therapeutics operates as a biotechnology company focused on immuno-oncology for cancer patients. Clasp Therapeutics is revolutionizing immuno-oncology with next-generation T cell engagers (TCEs), focusing on creating precision medicines to treat cancers that don't respond to current treatments. The company goal is on developing personalized treatments that use the immune system to identify and kill cancers with common driver mutations across cancer types. Clasp's technique targets modification protein fragments found in cancer cells, a concept that has the potential to significantly expand the reach of current immuno-oncology medicines by targeting cancer-driving proteins inside cells that were previously invisible to similar drugs.
Who invested in Clasp Therapeutics
9 investors across 1 round
See all investors in Clasp Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 10, 2023
Amount
$72M
Investors
Questions about Clasp Therapeutics
Who invested in Clasp Therapeutics?
Clasp Therapeutics has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Clasp Therapeutics raised?
Clasp Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Clasp Therapeutics last raise money?
Clasp Therapeutics's most recent round on record is a Series A, in Oct 2023.
What does Clasp Therapeutics do?
Based in Maryland, US, and founded in 2020, Clasp Therapeutics operates as a biotechnology company focused on immuno-oncology for cancer patients.
Where is Clasp Therapeutics headquartered?
Clasp Therapeutics is headquartered in Rockville, US.
Which VCs invest in companies like Clasp Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Clasp Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Clasp Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.